Barry Siegel, MD, a professor of radiology and of medicine at Washington University School of Medicine in St. Louis and the university’s Mallinckrodt Institute of Radiology (MIR), has been named a fellow of the Society of Nuclear Medicine and Molecular Imaging. He is one of 14 fellows recognized in June for distinguished service to the society as well as exceptional achievement in scientific discovery and innovation, educational efforts or clinical practice of nuclear medicine and molecular imaging.
Siegel has made contributions related to the diagnosis of blockages in lung arteries, the detection of blood clots, and using radioactive tracers to detect tumors. For the past two decades, his research has focused on uses of positron emission tomography (PET) for cancer diagnosis and staging, as well as predicting and monitoring tumor response to therapy. He played a leading role in working with the Centers for Medicare & Medicaid Services to set up a national registry that allowed for expanded access to PET for clinical applications in oncology.
As director of the Division of Nuclear Medicine at MIR for more than 40 years before stepping down in 2017, Siegel guided the development of an exceptional clinical nuclear medicine division, including important contributions to MIR’s world-renowned PET program.